Quest for the right Drug

|
עמוד הבית / נבנק / מידע מעלון לרופא

נבנק NEVANAC (NEPAFENAC)

תרופה במרשם תרופה בסל נרקוטיקה ציטוטוקסיקה

צורת מתן:

עיני : OCULAR

צורת מינון:

תרחיף לעין : EYE DROPS, SUSPENSION

Posology : מינונים

4.2    Posology and method of administration

Posology
Adults, including the elderly
For the prevention and treatment of pain and inflammation, the dose is 1 drop of NEVANAC in the conjunctival sac of the affected eye(s) 3 times daily beginning 1 day prior to cataract surgery, continued on the day of surgery and up to 21 days of the postoperative period, as directed by the clinician. An additional drop should be administered 30 to 120 minutes prior to surgery.

For the reduction in the risk of postoperative macular oedema associated with cataract surgery in diabetic patients, the dose is 1 drop of NEVANAC in the conjunctival sac of the affected eye(s) 3 times daily beginning 1 day prior to cataract surgery, continued on the day of surgery and up to 60 days of the postoperative period as directed by the clinician. An additional drop should be administered 30 to 120 minutes prior to surgery.

Special populations
Patients with renal or hepatic impairment

NEVANAC has not been studied in patients with hepatic disease or renal impairment. Nepafenac is eliminated primarily through biotransformation and the systemic exposure is very low following topical ocular administration. No dose adjustment is warranted in these patients.

Paediatric population
The safety and efficacy of NEVANAC in children and adolescents have not been established. No data are available. Its use is not recommended in these patients until further data become available.
Geriatric population
No overall differences in safety and effectiveness have been observed between elderly and younger patients.

Method of administration
For ocular use.

Patients should be instructed to shake the bottle well before use. After cap is removed, if tamper evident snap collar is loose, remove before using product.

If more than one topical ophthalmic medicinal product is being used, the medicinal product must be administered at least 5 minutes apart. Eye ointments should be administered last.

To prevent contamination of the dropper tip and solution, care must be taken not to touch the eyelids, surrounding areas or other surfaces with the dropper tip of the bottle. Patients should be instructed to keep the bottle tightly closed when not in use.

If a dose is missed, a single drop should be applied as soon as possible before reverting to regular routine. Do not use a double dose to make up for the 1 missed.

שימוש לפי פנקס קופ''ח כללית 1994 לא צוין
תאריך הכללה מקורי בסל לא צוין
הגבלות לא צוין

בעל רישום

NOVARTIS ISRAEL LTD

רישום

143 57 31467 00

מחיר

0 ₪

מידע נוסף

עלון מידע לרופא

01.06.22 - עלון לרופא

עלון מידע לצרכן

10.08.22 - עלון לצרכן אנגלית 10.08.22 - עלון לצרכן עברית 10.08.22 - עלון לצרכן ערבית 10.12.12 - החמרה לעלון 12.01.16 - החמרה לעלון 05.02.17 - החמרה לעלון 01.06.22 - החמרה לעלון

לתרופה במאגר משרד הבריאות

נבנק

קישורים נוספים

RxList WebMD Drugs.com